Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009
Bianca R. Perri , Douglas Proops, Patrick K. Moonan, Sonal S. Munsiff, Barry N. Kreiswirth, Natalia Kurepina, Christopher Goranson, and Shama D. Ahuja
Author affiliations: Author affiliations: New York City Department of Health and Mental Hygiene, New York, New York, USA (B.R. Perri, D. Proops, S.S. Munsiff, C. Goranson, S.D. Ahuja); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (B.R. Perri, P.K. Moonan, S.S. Munsiff); Public Health Research Institute Tuberculosis Center, Newark, New Jersey, USA (B.N. Kreiswirth, N. Kurepina)
Figure 4. Common characteristics among 54 patients infected with Mycobacterium tuberculosis, by year of tuberculosis diagnosis and drug susceptibility testing results, New York, New York, USA, 2003–2009.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.